2026 NPPES data Ophthalmology Physician NPI 1487642682 MD
Verify on CMS →

NICHOLAS STATHOPOULOS, MD

Ophthalmology Physician in TONAWANDA, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
4K
Medicare Part D claims · 1K beneficiaries · Ophthalmology Physician avg: 1K
Generic prescribing
48%
generic claims · 52% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
83.4048/100
▲ 0 pts above national avg 83.1 · [object Object]
Industry payments
$2.5K
95 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

NICHOLAS STATHOPOULOS, MD reported a CMS MIPS final score of 83.4048/100 — above the 83.1 national average — and filed 4,143 Medicare Part D claims in 2023.

83.4048/100
MIPS score · +0 vs avg
4K
Part D claims, 2023
48%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

NICHOLAS STATHOPOULOS, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

83 42nd percentile higher than 42% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

NICHOLAS STATHOPOULOS, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about NICHOLAS STATHOPOULOS, MD?

Near national average

NPI registry status

Active

Issued 10/11/2005

NPI 1487642682

Primary specialty

Ophthalmology Physician

Mid-sized

22,090 US NPIs in this specialty

Medicare Part D claims

4,143 192% vs specialty avg

2023 prescription claims

Specialty avg: 1,420

MIPS final score

83.4048/100 0.3048000000000002% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in New York

How Ophthalmology Physician compares to other specialties among New York providers

New York providers

Ophthalmology Physician share within New York

1. Ophthalmology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Ophthalmology Physician share within New York

Medicare quality performance — MIPS

NICHOLAS STATHOPOULOS, MD's 2023 MIPS final score plotted against the Ophthalmology Physician national average

Near national average
MIPS Final Score
83.4048/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Ophthalmology Physician) — 83.4048/100 vs national avg 83.1

0%100%National avg83%83.4%
MIPS final score (Ophthalmology Physician) — 83.4048/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

NICHOLAS STATHOPOULOS, MD appears in the CMS NPPES registry as a Ophthalmology Physician provider holding MD credentials at 1890 COLVIN BLVD, TONAWANDA, NY, 14150, with a listed phone of (716) 837-5200. NPI 1487642682 was issued on 10/11/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what STATHOPOULOS most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 4,143 prescription claims written by this provider, covering 1,269 Medicare beneficiaries and totaling roughly $1.7 million in drug spend, split 52% brand-name and 48% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 83.4048/100 for the 2023 performance year (Quality 80.283, Cost 70.972), compared with the national average of 83.1.

Ophthalmology Physician is a mid-sized specialty nationwide, with 22,090 enrolled providers across 56 states and an average of 1,420 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1890 COLVIN BLVD
TONAWANDA, NY 14150

Provider Details

NPI 1487642682
Specialty Ophthalmology Physician
Credentials MD
Gender Male
NPI Issued 10/11/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

83.4048
Final Score
Avg: 83.1
80.283
Quality
70.972
Cost

Reporting: Individual

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for NICHOLAS STATHOPOULOS, MD. Source: openpaymentsdata.cms.gov.

Total received

$2.5K

Largest payer

Alcon Vision LLC

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to NICHOLAS STATHOPOULOS, MD. To verify NICHOLAS STATHOPOULOS, MD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

NICHOLAS STATHOPOULOS, MD — brand share 52.0%
Specialty average (est.)

52% brand-name claims vs 48% generic, on 4,143 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

4,143
Total Claims
$1.7M
Total Drug Cost
1,269
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
8,111
Total Day Supply
233,855
Brand vs Generic
52% brand / 48% generic
Brand Drug Cost
$1.5M
Generic Drug Cost
$249K
Antibiotic Claims
54

Patient Demographics

Average Patient Age
77.6 years
Avg HCC Risk Score
1.16
Gender Split
72% female / 28% male
Age Distribution
<65: 14, 65-74: 467, 75-84: 524, 85+: 264

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What NICHOLAS STATHOPOULOS, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Latanoprost
723
Cyclosporine
698
Fluorometholone
504
Erythromycin
Erythromycin Base
323
Xiidra
Lifitegrast
291
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
252
Lumigan
Bimatoprost
195
Neomycin-Polymyxin-Dexameth
Neomycin/Polymyxin B/Dexametha
156
Restasis
Cyclosporine
150
Bimatoprost
89

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Ophthalmology Physician Overview

How NICHOLAS STATHOPOULOS, MD fits within the Ophthalmology Physician landscape nationally.

22,090
Ophthalmology Physician Providers in US
56
States with Ophthalmology Physician
1,420
Avg Claims per Provider

NICHOLAS STATHOPOULOS, MD's 4,143 claims are above the specialty average of 1,420.

Nearby Ophthalmology Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as STATHOPOULOS.

Compare Ophthalmology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is NICHOLAS STATHOPOULOS, MD's specialty?
NICHOLAS STATHOPOULOS, MD specializes in Ophthalmology Physician and practices in TONAWANDA, New York. Credentials: MD.
How much does NICHOLAS STATHOPOULOS, MD prescribe under Medicare Part D?
In 2023, NICHOLAS STATHOPOULOS, MD wrote 4,143 Medicare Part D claims totaling $1.7M in drug costs for 1,269 beneficiaries.
What is NICHOLAS STATHOPOULOS, MD's Medicare quality score?
NICHOLAS STATHOPOULOS, MD has a CMS MIPS Final Score of 83.4048/100 (Quality: 80.283, Cost: 70.972). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is NICHOLAS STATHOPOULOS, MD located?
NICHOLAS STATHOPOULOS, MD is located at 1890 COLVIN BLVD, TONAWANDA, NY, 14150. Phone: (716) 837-5200.
What is NICHOLAS STATHOPOULOS, MD's NPI number?
NICHOLAS STATHOPOULOS, MD's National Provider Identifier (NPI) is 1487642682, issued on 10/11/2005.
Does NICHOLAS STATHOPOULOS, MD prescribe more brand-name or generic drugs?
NICHOLAS STATHOPOULOS, MD's prescribing is 52% brand-name and 48% generic drugs by claim count, with $1.5M in brand drug costs.
How many Ophthalmology Physician providers are there in the US?
There are 22,090 Ophthalmology Physician providers across 56 states in the US. The average Ophthalmology Physician provider writes 1,420 Medicare Part D claims per year.
What drugs does NICHOLAS STATHOPOULOS, MD prescribe most often?
Based on 2023 Medicare Part D data, NICHOLAS STATHOPOULOS, MD's most frequently prescribed drugs include Latanoprost, Cyclosporine, Fluorometholone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does NICHOLAS STATHOPOULOS, MD accept Medicare?
NICHOLAS STATHOPOULOS, MD appears in CMS Medicare data with 4,143 Part D claims and 1,269 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify NICHOLAS STATHOPOULOS, MD's credentials?
NICHOLAS STATHOPOULOS, MD's NPI is 1487642682 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology